Clinical Trials Directory

Trials / Completed

CompletedNCT01795495

Methadone vs Magnesium in Spinal Fusion

Analgesia Following Posterior Spinal Fusion: Methadone vs Magnesium

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
63 (actual)
Sponsor
Nationwide Children's Hospital · Academic / Other
Sex
All
Age
12 Years – 19 Years
Healthy volunteers
Not accepted

Summary

Significant pain may occur following posterior spinal fusion despite the use of conventionally accepted techniques including patient controlled analgesia. If detected, a significant reduction in opioid requirements may lead to improved patient satisfaction and decreased opiate side effects. The current study would use a prospective, randomized trial investigating the efficacy of one of 2 regimens as adjuncts to intraoperative anesthesia and postoperative analgesia, along with a third control group. The patients would be randomized to receive remifentanil plus a single intraoperative dose of methadone; remifentanil plus a bolus followed by an infusion of magnesium; or remifentanil alone. In addition, the two medications being studied might make it easier to determine the efficacy of neurophysiologic monitoring including somatosensory evoked potential (SSEP) (amplitude and latency) and motor evoked potential (MEP) (mA) required to elicit the response. The purpose of this study would be to explore the effects of intraoperative methadone vs magnesium on intraoperative anesthetic requirements, postoperative opioid requirements, the efficacy of neurophysiologic monitoring including SSEP and MEP, inspired concentration of desflurane, remifentanil, and the need for intraoperative supplemental agents to control blood pressure.

Conditions

Interventions

TypeNameDescription
DRUGMethadone hydrochlorideThis drug will be used in conjunction with remifentanil as an adjunct analgesic. Remifentanil + methadone (0.1 mg/kg IV over 15 minutes) just after induction of anesthesia
DRUGMagnesium SulfateThis drug will be given with remifentanil as an adjunct analgesic. Remifentanil + magnesium (50 mg/kg bolus over 30 minutes followed by 10 mg/kg/hour).
DRUGRemifentanil

Timeline

Start date
2013-09-01
Primary completion
2016-08-01
Completion
2016-09-01
First posted
2013-02-20
Last updated
2018-02-08
Results posted
2018-02-08

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01795495. Inclusion in this directory is not an endorsement.